--- title: "Pre-market hot trades in US stocks: Baosheng Media pre-market down 3.46%; Cerebras pre-market down 3.39%" type: "News" locale: "en" url: "https://longbridge.com/en/news/294064779.md" description: "Baosheng Media pre-market down 3.46%; Cerebras pre-market down 3.39%; C3is pre-market up 92.38%; T3 Defense pre-market up 53.66%; Gossamer Bio pre-market up 49.85%" datetime: "2026-07-28T12:18:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294064779.md) - [en](https://longbridge.com/en/news/294064779.md) - [zh-HK](https://longbridge.com/zh-HK/news/294064779.md) --- # Pre-market hot trades in US stocks: Baosheng Media pre-market down 3.46%; Cerebras pre-market down 3.39% **Pre-market Hot Trades in US Stocks** Baosheng Media fell 3.46% in pre-market trading. Based on recent key news: 1. On July 27, Baosheng Media announced a partnership with an AI company, expecting to significantly boost its AI-driven business revenue, with a goal of AI services accounting for 30% of total revenue in the short term. Although this news has positive implications for the company's future development, the market reacted cautiously, leading to a pre-market decline in stock price. 2. On July 27, there was uncertainty in the market regarding Baosheng Media's AI business prospects, with investors concerned about whether the expected targets could be achieved in the short term, affecting stock performance. 3. No other significant news recently. The AI industry has broad prospects, but short-term volatility risks are high. Cerebras fell 3.39% in pre-market trading. Based on recent key news: 1. On July 28, Mizuho raised the target price for Cerebras Systems from $300 to $310, maintaining an "Outperform" rating. This move indicates analysts' optimism about the company's future performance, but it did not immediately boost the stock price. 2. On July 25, MarketBeat pointed out that although Cerebras Systems currently has a "Moderate Buy" rating among analysts, top analysts believe there are five other stocks that are more worthy of investment. This may lead to insufficient investor confidence in Cerebras, affecting stock performance. The market's preference for tech stocks has shifted. **Top Gainers in Pre-market US Stocks** C3is rose 92.38% in pre-market trading. Based on recent key news: 1. On July 27, C3is announced a public offering at a price of $0.52 per unit for $6 million. This news drove a significant increase in stock price. 2. On July 25, C3is executed a 1-for-7 reverse stock split to regain compliance and expand its fleet, reporting a 358% surge in adjusted net income for the first quarter to $5.5 million. This move bolstered market confidence. 3. On July 27, C3is announced that its public offering includes one share of common stock and one Class F warrant per unit, with the warrants immediately exercisable at a price of $0.52 per share and expiring within a year. This news further boosted the stock price. The infrastructure investment peak period shows strong industry performance. T3 Defense rose 53.66% in pre-market trading. No significant news recently; trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows notable volatility, with specific reasons needing further observation. no\_news Gossamer Bio rose 49.85% in pre-market trading. Based on recent key news: 1. On July 28, after a meeting with the FDA, Gossamer Bio plans to submit a new drug application for seralutinib in September 2026, driving the stock price up. The company also regained global development and commercial rights for the drug, further enhancing market confidence 2. On July 27th, the company's shareholders approved the exchange of convertible notes and a reverse stock split, aimed at optimizing the capital structure. This move reduced the debt burden, supported compliance with NASDAQ's minimum bid requirements, and boosted the stock price. 3. On July 27th, the company announced that its cash and cash equivalents amounted to approximately $57 million, enhancing financial stability and supporting the rise in stock price. Recent policy support for the biopharmaceutical industry has led to significant capital inflows ### Related Stocks - [BAOS.US](https://longbridge.com/en/quote/BAOS.US.md) - [CBRS.US](https://longbridge.com/en/quote/CBRS.US.md) - [CISS.US](https://longbridge.com/en/quote/CISS.US.md) - [DFNS.US](https://longbridge.com/en/quote/DFNS.US.md) - [GOSS.US](https://longbridge.com/en/quote/GOSS.US.md) ## Related News & Research - [CleanCore’s $800M AI Contract Shows Dogecoin Treasury Firms Are Changing Shape](https://longbridge.com/en/news/294544751.md) - [Amundi Grows Stake in Perpetua Resources Corp. $PPTA](https://longbridge.com/en/news/294653655.md) - [Essential Partners LLC Has $137,000 Position in 3M Company $MMM](https://longbridge.com/en/news/294599595.md) - [South Dakota Investment Council Lowers Stock Holdings in TransUnion $TRU](https://longbridge.com/en/news/294579954.md) - [Key facts: AAL EBITDA +35%, ROCE 19%; not in exclusive De Beers talks](https://longbridge.com/en/news/294469866.md)